{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:41:57Z","timestamp":1649108517725},"reference-count":221,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.hfc.2008.04.001","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T14:40:46Z","timestamp":1220020846000},"page":"479-503","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction: Role of the Kidney"],"prefix":"10.1016","volume":"4","author":[{"given":"Abhijit A.","family":"Shinde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hfc.2008.04.001_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure. Part II: causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pcad.2005.02.010","article-title":"Epidemiology of diastolic heart failure","volume":"47","author":"Owan","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/hrt.2005.074187","article-title":"Heart failure with a normal ejection fraction","volume":"93","author":"Sanderson","year":"2007","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/heart.89.11.1281","article-title":"Diastolic heart failure: fact or fiction?","volume":"89","author":"Sanderson","year":"2003","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000053947.82595.03","article-title":"Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?","volume":"107","author":"Burkhoff","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.hfc.2008.04.001_bib7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J\u00a0Med"},{"issue":"25","key":"10.1016\/j.hfc.2008.04.001_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM197206222862507","article-title":"Pulmonary edema in coronary-artery disease without cardiomegaly: paradox of the stiff heart","volume":"286","author":"Dodek","year":"1972","journal-title":"N Engl J\u00a0Med"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1527-5299.2006.04790.x","article-title":"Chronic heart failure: a report from the Dartmouth diastole discourses","volume":"12","author":"Quinones","year":"2006","journal-title":"Congest Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/jcaf.2003.9","article-title":"Systolic and diastolic dysfunction in heart failure? Time for a new paradigm","volume":"9","author":"Konstam","year":"2003","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1377\/hlthaff.26.1.75","article-title":"Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement","volume":"26","author":"Krumholz","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2006.12.012","article-title":"Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure","volume":"49","author":"Zile","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1527-5299.2007.06624.x","article-title":"Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction","volume":"13","author":"Mielniczuk","year":"2007","journal-title":"Congest Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cardfail.2007.01.010","article-title":"Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis","volume":"13","author":"Somaratne","year":"2007","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2006.03.032","article-title":"The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis","volume":"116","author":"Whalley","year":"2007","journal-title":"Int J\u00a0Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib19","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0735-1097(01)01567-4","article-title":"Heart failure with preserved systolic function: a different natural history?","volume":"38","author":"Senni","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(99)00399-5","article-title":"Diastolic heart failure","volume":"45","author":"Mandinov","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"17","key":"10.1016\/j.hfc.2008.04.001_bib22","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","article-title":"Defining diastolic heart failure: a call for standardized diagnostic criteria","volume":"101","author":"Vasan","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jacc.2005.09.032","article-title":"Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography","volume":"47","author":"Oh","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2008.04.001_bib24","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/01.CIR.0000164273.57823.26","article-title":"Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure","volume":"111","author":"Baicu","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/heart.87.2.121","article-title":"Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?","volume":"87","author":"Yip","year":"2002","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/hc1002.105185","article-title":"Progression of systolic abnormalities in patients with \u201cisolated\u201d diastolic heart failure and diastolic dysfunction","volume":"105","author":"Yu","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.CIR.0000117405.74491.D2","article-title":"Mechanisms of exercise intolerance: insights from tissue Doppler imaging","volume":"109","author":"Skaluba","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hfc.2008.04.001_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","article-title":"What mechanisms underlie diastolic dysfunction in heart failure?","volume":"94","author":"Kass","year":"2004","journal-title":"Circ Res"},{"issue":"19","key":"10.1016\/j.hfc.2008.04.001_bib30","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMp048064","article-title":"Understanding \u201cdiastolic\u201d heart failure","volume":"350","author":"Redfield","year":"2004","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.hfc.2008.04.001_bib31","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"Diez","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.CIR.93.5.1026","article-title":"Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis","volume":"93","author":"Diez","year":"1996","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1527-5299.2005.04479.x","article-title":"Are myocardial fibrosis and diastolic dysfunction reversible in hypertensive heart disease?","volume":"11","author":"Weber","year":"2005","journal-title":"Congest Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacc.2006.04.004","article-title":"Extracellular matrix remodeling in hypertensive heart disease","volume":"48","author":"Shirwany","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2008.04.001_bib37","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.hfc.2008.04.001_bib38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jacc.2007.06.018","article-title":"The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT echo study","volume":"50","author":"Verma","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","article-title":"Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The cardiovascular health study","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.hfc.2008.04.001_bib40","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3317\/jraas.2006.012","article-title":"From hypertension to heart failure: are there better primary prevention strategies?","volume":"7","author":"Meredith","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2006.02.001","article-title":"From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease","volume":"48","author":"Gradman","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.jhh.1001820","article-title":"Hypertension: still an important cause of heart failure?","volume":"19","author":"Kazzam","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"10 Suppl 2","key":"10.1016\/j.hfc.2008.04.001_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1524-6175.2004.03919.x","article-title":"From hypertension to heart failure","volume":"6","author":"Papademetriou","year":"2004","journal-title":"J Clin Hypertens"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1527-5299.2003.00798.x","article-title":"Heart failure in the elderly","volume":"9","author":"Forman","year":"2003","journal-title":"Congest Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00001573-200207000-00008","article-title":"Diastolic dysfunction in hypertension","volume":"17","author":"Slama","year":"2002","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11886-002-0050-4","article-title":"Prevention of heart failure","volume":"4","author":"Horwich","year":"2002","journal-title":"Curr Cardiol Rep"},{"issue":"20","key":"10.1016\/j.hfc.2008.04.001_bib48","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib49","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jama.281.7.634","article-title":"Increased pulse pressure and risk of heart failure in the elderly","volume":"281","author":"Chae","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(00)00687-2","article-title":"Pulse pressure and risk for myocardial infarction and heart failure in the elderly","volume":"36","author":"Vaccarino","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","article-title":"Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham heart study","volume":"138","author":"Haider","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2005.09.002","article-title":"Mechanisms of target organ damage caused by hypertension: therapeutic potential","volume":"111","author":"Cohuet","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-6175.2005.04119.x","article-title":"Hypertensive heart disease","volume":"7","author":"Prisant","year":"2005","journal-title":"J Clin Hypertens"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/bja\/aeh091","article-title":"Hypertension, hypertensive heart disease and perioperative cardiac risk","volume":"92","author":"Howell","year":"2004","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0733-8651(02)00004-8","article-title":"The heart, kidney, and brain as target organs in hypertension","volume":"20","author":"Mensah","year":"2002","journal-title":"Cardiol Clin"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/heart.86.4.467","article-title":"Essential hypertension: the heart and hypertension","volume":"86","author":"Berkin","year":"2001","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11906-996-0042-7","article-title":"Hypertension and the heart","volume":"2","author":"Susic","year":"2000","journal-title":"Curr Hypertens Rep"},{"issue":"20","key":"10.1016\/j.hfc.2008.04.001_bib58","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1053\/euhj.2000.2339","article-title":"Hypertensive heart disease: a complex syndrome or a hypertensive cardiomyopathy?","volume":"21","author":"Lip","year":"2000","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib59","first-page":"S15","article-title":"The role of systolic blood pressure in determining risk for cardiovascular disease","volume":"17","author":"Levy","year":"1999","journal-title":"J Hypertens Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2008.04.001_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000047287","article-title":"Mechanisms of development of heart failure in the hypertensive patient","volume":"92","author":"Bristow","year":"1999","journal-title":"Cardiology"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2008.04.001_bib61","first-page":"S9","article-title":"Hypertension and the development of heart failure","volume":"32","author":"de Leeuw","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00041552-199603000-00016","article-title":"Cardiac hypertrophy and failure in hypertension","volume":"5","author":"Johnson","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl J","key":"10.1016\/j.hfc.2008.04.001_bib63","first-page":"76","article-title":"Origin and mechanisms of heart failure in hypertensive patients: left ventricular remodelling in hypertensive heart disease","volume":"14","author":"Dubus","year":"1993","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","article-title":"The pathophysiology of acute heart failure: is it all about fluid accumulation? ECM remodeling in hypertensive heart disease from left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease","volume":"155","author":"Cotter","year":"2008","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"issue":"18","key":"10.1016\/j.hfc.2008.04.001_bib66","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/CIRCULATIONAHA.105.544031","article-title":"Role of diuretics in the prevention of heart failure: the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"113","author":"Davis","year":"2006","journal-title":"Circulation"},{"issue":"9395","key":"10.1016\/j.hfc.2008.04.001_bib67","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Blood pressure lowering treatment trialists C. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.hfc.2008.04.001_bib68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(03)14294-8","article-title":"Candesartan and heart failure: the allure of CHARM","volume":"362","author":"White","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib69","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0195-668X(02)00804-7","article-title":"Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease","volume":"24","author":"Group","year":"2003","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.hfc.2008.04.001_bib70","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"issue":"9246","key":"10.1016\/j.hfc.2008.04.001_bib71","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"issue":"9246","key":"10.1016\/j.hfc.2008.04.001_bib72","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(00)03306-7","article-title":"Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials","volume":"356","author":"Pahor","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib73","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib74","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","article-title":"Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans","volume":"16","author":"Rossi","year":"1998","journal-title":"J\u00a0Hypertens"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1524-6175.2006.05366.x","article-title":"Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy","volume":"8","author":"Kjeldsen","year":"2006","journal-title":"J\u00a0Clin Hypertens"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.HYP.0000226859.42064.ea","article-title":"Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy\/failure","volume":"48","author":"Perlini","year":"2006","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.hfc.2008.04.001_bib77","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1001\/jama.292.19.2396","article-title":"Left ventricular hypertrophy: the next treatable, silent killer?","volume":"292","author":"Gardin","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib78","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.0000137118.47943.5C","article-title":"Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial","volume":"110","author":"Ciulla","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.04.001_bib79","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1046\/j.1523-1755.1998.06724.x","article-title":"Pathophysiology of renal fluid retention","volume":"67","author":"Schrier","year":"1998","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib80","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00608-7","article-title":"The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction","volume":"35","author":"Dries","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib81","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11897-004-0024-5","article-title":"Interactions between the sympathetic nervous system and the RAAS in heart failure","volume":"1","author":"Goldsmith","year":"2004","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00129784-200606060-00004","article-title":"Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention","volume":"6","author":"Bernal","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"issue":"13","key":"10.1016\/j.hfc.2008.04.001_bib84","doi-asserted-by":"crossref","first-page":"18D","DOI":"10.1016\/S0002-9149(99)80487-1","article-title":"The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy","volume":"76","author":"Raman","year":"1995","journal-title":"Am J Cardiol"},{"issue":"17","key":"10.1016\/j.hfc.2008.04.001_bib85","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198810273191705","article-title":"Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy: Part II","volume":"319","author":"Schrier","year":"1988","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.hfc.2008.04.001_bib86","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198810203191606","article-title":"Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy: Part I","volume":"319","author":"Schrier","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0002-9149(87)91009-5","article-title":"Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition","volume":"60","author":"Packer","year":"1987","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib88","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1152\/ajplegacy.1976.231.3.936","article-title":"Stretch receptor model for renin release with evidence from perfused rat kidney","volume":"231","author":"Fray","year":"1976","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.100.1.82","article-title":"Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure","volume":"100","author":"DiBona","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib91","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1172\/JCI108069","article-title":"Effects of acute unilateral renal denervation in the rat","volume":"56","author":"Bello-Reuss","year":"1975","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib93","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM198809083191007","article-title":"Prerenal failure: a deleterious shift from renal compensation to decompensation","volume":"319","author":"Badr","year":"1988","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib94","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/08860220600839522","article-title":"Adaptation of renal function in heart failure","volume":"28","author":"Makaritsis","year":"2006","journal-title":"Ren Fail"},{"issue":"18","key":"10.1016\/j.hfc.2008.04.001_bib95","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","volume":"345","author":"Vasan","year":"2001","journal-title":"N Engl J Med"},{"issue":"9349","key":"10.1016\/j.hfc.2008.04.001_bib96","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib97","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0735-1097(98)00679-2","article-title":"Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction","volume":"33","author":"Domanski","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11936-005-0006-2","article-title":"Heart failure with preserved systolic function","volume":"7","author":"Domanski","year":"2005","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"9579","key":"10.1016\/j.hfc.2008.04.001_bib99","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(07)60980-5","article-title":"Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial","volume":"369","author":"Solomon","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ahj.2004.03.015","article-title":"Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the losartan intervention for endpoint reduction in hypertension (LIFE) study","volume":"148","author":"Wachtell","year":"2004","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib101","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.270.6.713","article-title":"Treatment of mild hypertension study: final results. Treatment of mild hypertension study research group","volume":"270","author":"Neaton","year":"1993","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.hfc.2008.04.001_bib102","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jacc.2007.07.032","article-title":"Impact of arterial load and loading sequence on left ventricular tissue velocities in humans","volume":"50","author":"Borlaug","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib103","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1152\/physrev.1982.62.2.570","article-title":"Vascular impedance in studies of arterial and cardiac function","volume":"62","author":"O'Rourke","year":"1982","journal-title":"Physiol Rev"},{"issue":"20","key":"10.1016\/j.hfc.2008.04.001_bib104","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMra021498","article-title":"Heart failure","volume":"348","author":"Jessup","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.hfc.2008.04.001_bib106","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib107","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"Gonzalez","year":"2004","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1388-9842(03)00052-7","article-title":"Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) programme","volume":"5","author":"McMurray","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"10.1016\/j.hfc.2008.04.001_bib110","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"9386","key":"10.1016\/j.hfc.2008.04.001_bib111","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib113","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9149(97)00320-2","volume":"80","author":"Aronow","year":"1997","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib114","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure: the digitalis investigation group","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"issue":"16","key":"10.1016\/j.hfc.2008.04.001_bib116","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/archinte.158.16.1743","article-title":"Chronic renal insufficiency: a diagnostic and therapeutic approach","volume":"158","author":"Rahman","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ahj.2006.10.022","article-title":"Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure","volume":"153","author":"Chinnaiyan","year":"2007","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib118","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2007.09.026","article-title":"Comparative effects of torasemide and furosemide in rats with heart failure","volume":"75","author":"Veeraveedu","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib119","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2004.09.009","article-title":"Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"44","author":"Tsutamoto","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib121","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2007.09.026","article-title":"Comparative effects of torasemide and furosemide in rats with heart failure","volume":"75","author":"Veeraveedu","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib122","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ahj.2007.04.017","article-title":"Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure (Am Heart J 2007;153:189-200)","volume":"154","author":"Jolobe","year":"2007","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib123","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib124","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1253\/circj.67.384","article-title":"Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure","volume":"67","author":"Yamato","year":"2003","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000022097","article-title":"Age-dependent changes of the kidneys: pharmacological implications","volume":"45","author":"Muhlberg","year":"1999","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib127","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","article-title":"Diuretic complications","volume":"319","author":"Greenberg","year":"2000","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling: concepts and clinical implications. A consensus paper from an international forum on cardiac remodeling: behalf of an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib129","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.hjh.0000165623.72310.dd","article-title":"The cardiovascular continuum and renin-angiotensin-aldosterone system blockade","volume":"23","author":"Dzau","year":"2005","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.hfc.2008.04.001_bib130","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.90.4.1731","article-title":"Effects of captopril on ischemic events after myocardial infarction: results of the survival and ventricular enlargement trial. SAVE investigators","volume":"90","author":"Rutherford","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2008.04.001_bib132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajh\/5.2.95","article-title":"Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies","volume":"5","author":"Dahlof","year":"1992","journal-title":"Am J\u00a0Hypertens"},{"issue":"12","key":"10.1016\/j.hfc.2008.04.001_bib133","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib134","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00126097-200112000-00016","article-title":"Task force II: blood pressure measurement and cardiovascular outcome","volume":"6","author":"Staessen","year":"2001","journal-title":"Blood Press Monit"},{"issue":"9290","key":"10.1016\/j.hfc.2008.04.001_bib135","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"issue":"8951","key":"10.1016\/j.hfc.2008.04.001_bib136","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction.ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"8875","key":"10.1016\/j.hfc.2008.04.001_bib137","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib138","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: the survival of myocardial infarction long-term evaluation (SMILE) study investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2008.04.001_bib139","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1161\/01.CIR.95.12.2643","article-title":"Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction: the healing and early afterload reducing therapy trial","volume":"95","author":"Pfeffer","year":"1997","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hfc.2008.04.001_bib140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian enalapril survival study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib141","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.hfc.2008.04.001_bib142","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: trandolapril cardiac evaluation (TRACE) study group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"issue":"9215","key":"10.1016\/j.hfc.2008.04.001_bib143","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"9535","key":"10.1016\/j.hfc.2008.04.001_bib145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib146","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"9386","key":"10.1016\/j.hfc.2008.04.001_bib147","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.hfc.2008.04.001_bib148","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.hfc.2008.04.001_bib149","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1007740008155","article-title":"Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND investigators (Trial on Reversing Endothelial Dysfunction)","volume":"13","author":"Schlaifer","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib151","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1015709617405","article-title":"Pathophysiologic and therapeutic importance of tissue ACE: a consensus report","volume":"16","author":"Dzau","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib152","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.CIR.94.3.258","article-title":"Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study","volume":"94","author":"Mancini","year":"1996","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib153","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM200503033520919","article-title":"ACE inhibition in stable coronary artery disease","volume":"352","author":"Yusuf","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib154","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0002-9149(01)01461-8","article-title":"The quinapril ischemic event trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function","volume":"87","author":"Pitt","year":"2001","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART 2 collaborative research group: prevention of atherosclerosis with ramipril","volume":"36","author":"MacMahon","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib156","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jacc.2005.11.073","article-title":"Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Al-Mallah","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib157","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the losartan intervention for endpoint reduction in hypertension (LIFE) trial","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib158","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(99)00048-0","article-title":"Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise","volume":"33","author":"Warner","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib159","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0025-7125(02)00183-9","article-title":"Aldosterone as a target in congestive heart failure","volume":"87","author":"Rajagopalan","year":"2003","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib161","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4067\/S0716-97602004000100010","article-title":"Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives","volume":"37","author":"Abd-Allah","year":"2004","journal-title":"Biol Res"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-6363(00)00092-4","article-title":"Renin-angiotensin-aldosterone system and myocardial fibrosis","volume":"47","author":"Brilla","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib163","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11906-004-0022-8","article-title":"Mineralocorticoid receptor antagonists and hypertension: is there a rationale?","volume":"6","author":"Gumieniak","year":"2004","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib164","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.HYP.0000036399.80194.D8","article-title":"Aldosterone antagonist improves diastolic function in essential hypertension","volume":"40","author":"Grandi","year":"2002","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1291\/hypres.25.837","article-title":"Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension","volume":"25","author":"Sato","year":"2002","journal-title":"Hypertens Res"},{"issue":"10","key":"10.1016\/j.hfc.2008.04.001_bib166","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/clc.4960281008","article-title":"Spironolactone improves diastolic function in the elderly","volume":"28","author":"Roongsritong","year":"2005","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib167","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2007.03.062","article-title":"Aldosterone receptor antagonism induces remodeling when added to angiotensin receptor blockade in chronic heart failure","volume":"50","author":"Chan","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib168","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"Chrysostomou","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib169","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0735-1097(01)01516-9","article-title":"Metoprolol controlled release\/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study","volume":"38","author":"Goldstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib170","first-page":"31","article-title":"Carvedilol in the treatment of chronic heart failure: lessons from the carvedilol or metoprolol European trial","volume":"3","author":"Kveiborg","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib171","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2006.10.059","article-title":"Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET","volume":"49","author":"Remme","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"9A","key":"10.1016\/j.hfc.2008.04.001_bib172","doi-asserted-by":"crossref","first-page":"58B","DOI":"10.1016\/j.amjcard.2004.01.027","article-title":"Tolerability of carvedilol in heart failure: clinical trials experience","volume":"93","author":"Krum","year":"2004","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib173","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14734220310011716","article-title":"Use of beta-blockers in congestive heart failure","volume":"35","author":"Sallach","year":"2003","journal-title":"Ann Med"},{"issue":"9474","key":"10.1016\/j.hfc.2008.04.001_bib174","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0733-8651(05)70164-8","article-title":"Diastolic dysfunction in the elderly: genesis and diagnostic and therapeutic implications","volume":"18","author":"Kitzman","year":"2000","journal-title":"Cardiol Clin"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib176","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1291\/hypres.28.191","article-title":"Hypertensive heart disease","volume":"28","author":"Diamond","year":"2005","journal-title":"Hypertens Res"},{"issue":"4 Pt 1","key":"10.1016\/j.hfc.2008.04.001_bib177","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0002-8703(92)90709-5","article-title":"Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure","volume":"123","author":"Ghali","year":"1992","journal-title":"Am Heart J"},{"issue":"12 Pt 1","key":"10.1016\/j.hfc.2008.04.001_bib178","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.amjhyper.2004.07.007","article-title":"Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure","volume":"17","author":"Kobayashi","year":"2004","journal-title":"Am J Hypertens"},{"issue":"17","key":"10.1016\/j.hfc.2008.04.001_bib179","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"issue":"4 Suppl A","key":"10.1016\/j.hfc.2008.04.001_bib180","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1016\/0735-1097(93)90480-O","article-title":"Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry. The SOLVD investigators","volume":"22","author":"Benedict","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib181","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200201000-00002","article-title":"Sympathetic overactivity as a cause of hypertension in chronic renal failure","volume":"20","author":"Augustyniak","year":"2002","journal-title":"J Hypertens"},{"issue":"11A","key":"10.1016\/j.hfc.2008.04.001_bib182","doi-asserted-by":"crossref","first-page":"26L","DOI":"10.1016\/S0002-9149(97)00846-1","article-title":"Mechanism of action of beta-blocking agents in heart failure","volume":"80","author":"Bristow","year":"1997","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib183","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.RES.66.6.1610","article-title":"Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium","volume":"66","author":"Hall","year":"1990","journal-title":"Circ Res"},{"issue":"9169","key":"10.1016\/j.hfc.2008.04.001_bib184","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.hfc.2008.04.001_bib185","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ehj.2004.05.022","article-title":"Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR\/XL in elderly patients with heart failure","volume":"25","author":"Deedwania","year":"2004","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib186","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ahj.2007.03.025","article-title":"Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the study of the effects of nebivolol intervention on outcomes and rehospitalisation in seniors with heart failure (SENIORS) trial","volume":"154","author":"Dobre","year":"2007","journal-title":"Am Heart J"},{"issue":"9 Pt 2","key":"10.1016\/j.hfc.2008.04.001_bib187","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1016\/S0895-7061(03)00968-3","article-title":"Role for beta-blockers in the management of diabetic kidney disease","volume":"16","author":"Bakris","year":"2003","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib188","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib189","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejheart.2004.02.003","article-title":"Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function: results of the Swedish Doppler-echocardiographic study (SWEDIC)","volume":"6","author":"Bergstrom","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejheart.2006.07.008","article-title":"Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction: clinical implications and survival","volume":"9","author":"Dobre","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.hfc.2008.04.001_bib191","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the Euroheart failure survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib192","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-8703(03)00151-0","article-title":"Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction","volume":"146","author":"Kerzner","year":"2003","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib193","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib194","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","article-title":"Beta blockers in the management of chronic kidney disease","volume":"70","author":"Bakris","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0735-1097(01)01704-1","article-title":"Diastolic heart failure: neglected or misdiagnosed?","volume":"39","author":"Banerjee","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib196","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.CIR.72.4.853","article-title":"Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects","volume":"72","author":"Bonow","year":"1985","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2008.04.001_bib197","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0735-1097(02)01710-2","article-title":"Low-dose digoxin in patients with heart failure: less toxic and at least as effective?","volume":"39","author":"van Veldhuisen","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2008.04.001_bib198","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMp020118","article-title":"Digoxin: new perspective on an old drug","volume":"347","author":"Eichhorn","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2008.04.001_bib199","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00129784-200606020-00002","article-title":"Mechanisms, manifestations, and management of digoxin toxicity in the modern era","volume":"6","author":"Bauman","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib200","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cardfail.2005.06.432","article-title":"The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design","volume":"11","author":"Carson","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2008.04.001_bib201","unstructured":"NHBLI Fbt. TOPCAT. Available at: http:\/\/topcatstudy.com\/. Accessed January 21, 2008."},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","volume":"148","author":"Teo","year":"2004","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.hfc.2008.04.001_bib203","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib204","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2005.11.005","article-title":"HFSA 2006 comprehensive heart failure practice guideline","volume":"12","author":"Heart Failure Society of A","year":"2006","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0828-282X(06)70237-9","article-title":"Canadian cardiovascular society consensus conference recommendations on heart failure 2006: diagnosis and management","volume":"22","author":"Arnold","year":"2006","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib206","first-page":"509","volume":"63","author":"Swedberg","year":"2005","journal-title":"Kardiol Pol"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib207","first-page":"645","article-title":"The 2005 Canadian hypertension education program recommendations for the management of hypertension. Part 1: blood pressure measurement, diagnosis and assessment of risk","volume":"21","author":"Hemmelgarn","year":"2005","journal-title":"Can J\u00a0Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib208","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The Euroheart failure survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.hfc.2008.04.001_bib209","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/euhj.1999.1762","article-title":"A national survey of heart failure in French hospitals: the Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society","volume":"21","author":"Cohen-Solal","year":"2000","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2008.04.001_bib210","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1388-9842(01)00172-6","article-title":"Ambulatory heart failure management in private practice in France","volume":"3","author":"Komajda","year":"2001","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib211","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1388-9842(01)00142-8","article-title":"Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center","volume":"3","author":"Taubert","year":"2001","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2008.04.001_bib212","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(99)00006-6","article-title":"Drug-induced heart failure","volume":"33","author":"Feenstra","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 5A","key":"10.1016\/j.hfc.2008.04.001_bib213","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1016\/j.amjmed.2003.10.021","article-title":"New insights into diastolic heart failure: role of diabetes mellitus","volume":"116","author":"Piccini","year":"2004","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib214","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.104.519876","article-title":"Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report","volume":"112","author":"Fukuta","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hfc.2008.04.001_bib215","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jacc.2003.11.043","volume":"43","author":"Ogata","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2008.04.001_bib216","first-page":"77","article-title":"Biomarkers for chronic heart failure","volume":"5","author":"Lainscak","year":"2007","journal-title":"Heart Fail Monit"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib217","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2006.06.004","article-title":"Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization","volume":"117","author":"Bettencourt","year":"2007","journal-title":"Int J\u00a0Cardiol"},{"issue":"7","key":"10.1016\/j.hfc.2008.04.001_bib218","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardfail.2005.05.002","article-title":"B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function","volume":"11","author":"Valle","year":"2005","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib219","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacc.2003.07.037","article-title":"Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy","volume":"43","author":"Yamaguchi","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.hfc.2008.04.001_bib220","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hfc.2008.04.001_bib221","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccl.2007.11.001","article-title":"Role of neurohormonal modulators in heart failure with relatively preserved systolic function","volume":"26","author":"Rapp","year":"2008","journal-title":"Cardiol Clin"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171360800069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171360800069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T17:51:59Z","timestamp":1557769919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155171360800069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":221,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S155171360800069X"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2008.04.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}